Reasons to Retain Cooper Companies Stock in Your Portfolio for Now
Cooper Companies' premium contact lenses, restructuring gains and product launches support growth despite regional and competitive headwinds.
Zacks
More News
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now
West Pharmaceutical is riding on strong HVP demand, GLP-1 growth and Annex 1 adoption, but can these tailwinds outweigh capacity and concentration risks?
Zacks
Is This the Right Time to Hold MYGN Stock in Your Portfolio?
Myriad Genetics expands its testing portfolio and advances its Cancer Care Continuum strategy. Can reimbursement risks and cost pressures temper growth?
Zacks
Operation Smile Announces Align Technology as Title Sponsor of 34th International Student Leadership Conference for Sixth Year
Operation Smile Announces Align Technology as Title Sponsor of 34th International Student Leadership Conference for Sixth Year Operation Smile Announces Align Technology as Title Sponsor of 34th International Student Leadership Conference for Sixth Year PR Newswire VIRGINIA BEACH, Va., and TEMPE...
PR Newswire
Zacks Industry Outlook McKesson, Cardinal, West Pharmaceutical, Align and Henry
McKesson, Cardinal, West Pharmaceutical, Align and Henry have been highlighted in this Industry Outlook article.
Zacks
5 Medical Supply Stocks to Buy Amid Strong Industry Tailwinds
Here, we highlight five dental supplies stocks, MCK, CAH, WST, ALGN and HSIC, which are well positioned to generate wealth for investors amid improving industry prospect.
Zacks
ALGN vs. SAUHY: Which Stock Is the Better Value Option?
ALGN vs. SAUHY: Which Stock Is the Better Value Option?
Zacks
Here's Why Align Technology (ALGN) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks
Are Medical Stocks Lagging Aveanna Healthcare (AVAH) This Year?
Here is how Aveanna Healthcare (AVAH) and Align Technology (ALGN) have performed compared to their sector so far this year.
Zacks
Does NVST Stock Still Deserve a Place in Your Portfolio?
Envista executes on growth priorities with new products, acquisitions and global expansion, but macro, tariff and currency headwinds remain in focus.